一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> International Journal of Phytopharmacy >>article

International Journal of Phytopharmacy

Download PDF

Teneligliptin: DPP-4 inhibitor in the treatment of type II Diabetes Mellitus

Published:30 August 2017 DOI: 10.7439/IJPP.V7I4.4347
K. Danao, M. Shende, Rohit A. Gupta, Nitin G Dumore, U. Mahajan

Abstract

The collective review of teneligliptin as an antidibetic drug concerning about the mechanisms of action, pharmacokinetic study, pharmacodynamic study, toxicological study and dose and its contraindication. Teneligliptin is used in the treatment of type II diabetes mellitus. Teneligliptin, a third generation DPP-4 inhibitor, teneligliptin was approved by the US Food and Drug Administration on 2012 based on a large development program. Teneligliptin, a novel DPP-4 inhibitor, exhibits a unique structure characterized by five consecutive rings, which produce a potent and long-lasting effect. Teneligliptin is currently used in cases showing insufficient improvement in glycemic control even after diet control and exercise or a combination of diet control, exercise, and sulfonylurea or thiazolidine-class drugs. In adults, teneligliptin is orally administered at a dosage of 20 mg once daily, which can be increased up to 40 mg per day. Due to the metabolites of this drug are eliminated via renal and hepatic excretion so, adjustable dose is not required to renal impairment patient. In this review, all the clinical data is described. Teneligliptin shows promise in stabilizing glycemic fluctuations throughout the day and consequently suppressing the progression of diabetic complications.

Substances (4)

Related products
Procduct Name CAS Molecular Formula Supplier Price
THIAZOLIDINE 504-78-9 C3H7NS 276 suppliers $7.00-$930.18
Teneligliptin 760937-92-6 C22H30N6OS 192 suppliers $44.00-$1815.00
CAY10535 Exclusive 945716-28-9 C18H21N3O7S 13 suppliers $36.00-$1801.00
TRELAGLIPTIN(SYR-472) is a long-acting DPP-4 inhibitor. 3 suppliers Inquiry

Similar articles

IF:1.3

Teneligliptin: Heralding Change in Type 2 Diabetes

Journal of Database Management M. Maladkar,?Srividya Sankar,etc Published: 31 March 2016
IF:13

Linagliptin: in type 2 diabetes mellitus.

Drugs Lesley J Scott,etc Published: 26 March 2011
IF:13

Dapagliflozin: a review of its use in type 2 diabetes mellitus.

Drugs Greg L Plosker,etc Published: 3 December 2012
利津县| 南澳县| 玉田县| 荆州市| 莱阳市| 竹北市| 区。| 荃湾区| 灵山县| 巴林左旗| 琼中| 峡江县| 治县。| 丰原市| 井冈山市| 平谷区| 灌云县| 绍兴市| 阿坝县| 巴里| 团风县| 周至县| 来宾市| 屯门区| 昂仁县| 都江堰市| 北碚区| 九寨沟县| 卫辉市| 桦甸市| 剑河县| 壤塘县| 涿州市| 锡林郭勒盟| 盖州市| 叙永县| 扎赉特旗| 芮城县| 红安县| 乡宁县| 兴宁市|